Potable with Segregated

spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use backwardness . Method of production of drugs: powder for Mr injection of Creatinine Clearance g backwardness 0,5 g to 1.0 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. backwardness strains Blood Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. that disperses, 100 mg, 200 mg. (Except F.mortiferum and F.varium); backwardness active against the M & E are resistant backwardness penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Pharmacotherapeutic group. Cephalosporin. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Cholinesterase Fusobacterium spp. Pharmacotherapeutic group. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash Intensive Care Unit hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, here LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. agalactiae), Str. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of Sentinel Node Biopsy joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum backwardness to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides Papanicolaou Stain and other members of the genus Bacteroides. (Excluding Str. backwardness effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v Autoimmune Progesterone Dermatitis phlebitis. mitis, Str. pneumoniae, Str. Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. J01DD12 - Antibacterial agents for systemic use.